TORONTO, March 28 /CNW/ - Patheon announced today that the appointment of
Riccardo Trecroce as Chief Executive Officer of Patheon Inc. has been
confirmed for an indefinite period. Mr. Trecroce was initially appointed as
Chief Executive Officer for an interim period in September 2006.
"Since joining Patheon in 2000, Riccardo has played a key role in the
development and execution of Patheon's business strategy," said Peter Green,
Chairman of Patheon Inc. "Riccardo's in-depth knowledge of the company, strong
client focus and vision are qualities that will serve Patheon well as we move
forward to advance Patheon's positioning as a global leader in our sector."
Patheon (TSX:PTI; www.patheon.com) is a leading global provider of drug
development and manufacturing services to the international pharmaceutical
industry. Patheon operates a network of 14 facilities in the United States,
Canada and Europe, employing more than 5,300 people and serving a client base
of 250 pharmaceutical and biotechnology companies.
For further information:
For further information: Mr. Peter Green, Chairman, Patheon Inc., Tel:
(905) 812-6760, Fax: (905) 812-6613, Email: email@example.com; Mr.
Riccardo Trecroce, Chief Executive Officer, Patheon Inc., Tel: (905) 812-6877,
Fax: (905) 812-6613, Email: firstname.lastname@example.org; Ms. Shelley Jourard,
Director, Corporate Communications, Patheon Inc., Tel: (905) 812-6614, Fax:
(905) 812-6613; Email: email@example.com